Neurotrat MP Tablet
By Neurotrat
Rx
10 Tablet in a Strip

Composition
Methylcobalamin(NA) + Pregabalin(NA)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
November, 2025

liver
Neurotrat MP Tablet is considered safe for use in individuals with liver disease based on the limited available data. It is indicated that there may not be a requirement for dose adjustment of Neurotrat MP Tablet in such patients. However, it is always advisable to seek guidance from your doctor before using this medication, particularly if you have any liver-related concerns.

kidney
Neurotrat MP Tablet needs caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor.

alcohol
When taking Neurotrat MP Tablet, be cautious as it can lead to increased drowsiness when consumed with alcohol.

driving
Neurotrat MP Tablet may cause drowsiness, dizziness, and vision changes. Avoid driving if you experience these effects.

pregnancy
Neurotrat MP Tablet may not be safe to use during pregnancy. Studies on animals have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
Neurotrat MP Tablet is not recommended during breastfeeding as it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹151.78
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025